Search Results 1-10 of 16898 for Imiglucerase
Description. Imiglucerase injection is used to treat type 1 or type 3 Gaucher disease which may cause anemia (low number of red blood cells), ...
If you are also using imiglucerase, velaglucerase alfa, or taliglucerase alfa, take eliglustat 24 hours after taking the last dose of these medicines. Avoid ...
Taliglucerase alfa injection is used for the long-term treatment of type 1 Gaucher disease. This disease is caused by the lack of a certain enzyme in the body ...
Glucarpidase injection is used to treat too much methotrexate concentration in the blood in patients with severe kidney disease. This medicine is to be given ...
Description. Miglustat is used to treat mild to moderate type 1 Gaucher disease in people who cannot be treated with an enzyme replacement therapy.
Imipenem and cilastatin combination is used in the treatment of infections caused by bacteria. It works by killing bacteria or preventing their growth. This ...
These patients are at high risk for progression of kidney disease, which can result in end-stage renal failure. Participation eligibility. Participant ...
Imiglucerase (intravenous route) · Imipenem and cilastatin (intravenous route, intramuscular route) · Imipenem, cilastatin, and relebactam (intravenous route).
Umbralisib is used to treat marginal zone lymphoma (MZL) that has come back (relapsed) or did not respond to the treatment (refractory) in patients who have ...
Tell your doctor right away if you have increased hunger, cold sweats, blurred vision, fast heartbeat, shakiness, trembling, stomach pain, dark urine or light ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!